SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000898432-06-000701
Filing Date
2006-08-11
Accepted
2006-08-11 10:16:56
Documents
5
Group Members
ALAN FOGELMAN

Document Format Files

Seq Description Document Type Size
1 schedule13d.txt SC 13D 15001
2 EXHIBIT 99-1 exhibit99.txt EX-99 1071
3 EXHIBIT 99.2 irc_exh99-2.txt EX-99 56183
4 EXHIBIT 99.3 irc13d_ex99-3.txt EX-99 41544
5 EXHIBIT 99.4 exhibit994.txt EX-99 25024
  Complete submission text file 0000898432-06-000701.txt   140741
Mailing Address 5931 DARWIN COURT CARLSBAD CA 92008
Business Address 5931 DARWIN COURT CARLSBAD CA 92008 7604317080
IMMUNE RESPONSE CORP (Subject) CIK: 0000817785 (see all company filings)

IRS No.: 330255679 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45513 | Film No.: 061023248
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 535 MADISON AVENUE 18TH FLOOR NEW YORK NY 10022
Business Address 535 MADISON AVENUE 18TH FLOOR NEW YORK NY 10022 212-326-9200
QUBIT HOLDINGS LLC (Filed by) CIK: 0001336153 (see all company filings)

IRS No.: 201636991 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D